Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Mini Samples ELISA Kit for Monocyte Chemotactic Protein 3 (MCP3)
CCL7; FIC; MARC; NC28; MCP3; SCYA7; Chemokine C-C-Motif Ligand 7; Small Inducible Cytokine A7; Monocyte Chemoattractant Protein 3
- Product No.MEA089Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range15.6-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 6.1pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 545
For more details, please contact local distributors! US$ 778 US$ 3501 US$ 6613 US$ 54460
Specificity
This assay has high sensitivity and excellent specificity for detection of Mini Samples Monocyte Chemotactic Protein 3 (MCP3).
No significant cross-reactivity or interference between Mini Samples Monocyte Chemotactic Protein 3 (MCP3) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Mini Samples Monocyte Chemotactic Protein 3 (MCP3) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Monocyte Chemotactic Protein 3 (MCP3) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 81-95 | 88 |
EDTA plasma(n=5) | 85-103 | 93 |
heparin plasma(n=5) | 78-95 | 92 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Monocyte Chemotactic Protein 3 (MCP3) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Monocyte Chemotactic Protein 3 (MCP3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Monocyte Chemotactic Protein 3 (MCP3) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 87-104% | 84-94% | 92-102% | 84-102% |
EDTA plasma(n=5) | 85-94% | 82-102% | 78-99% | 82-94% |
heparin plasma(n=5) | 94-105% | 81-90% | 92-105% | 83-97% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×60µL | Assay Diluent A | 1×6mL |
Detection Reagent B | 1×60µL | Assay Diluent B | 1×6mL |
TMB Substrate | 1×4.5mL | Stop Solution | 1×3mL |
Wash Buffer (30 × concentrate) | 1×10mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;
3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 20µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Journal of Periodontal Research | Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study Pubmed:25604769 |
Journal of Histochmistry and Cytochmistry | Epigallocatechin-3-Gallate Attenuates Unilateral Ureteral Obstruction-Induced Renal Interstitial Fibrosis in Mice PubMed: 25549657 |
Cell Physiol Biochem | MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1 PubMed: 26159489 |
Cell Transplantation | Ex vivo Pretreatment of Islets with Mitomycin C: Reduction in Immunogenic Potential of Islets by Suppressing Secretion of Multiple Chemotactic Factors. pubmed:28901184 |
NPG Asia Materials | Molybdenum disulfide/graphene oxide nanocomposites show favorable lung targeting and enhanced drug loading/tumor-killing efficacy with improved … Articles:am2017225 |
FASEB Journal | Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis Pubmed:29863913 |